Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Resolutions for the General Meeting of Shareholders
Annual, 22nd2026
Jun 26
Date and time23 days from this disclosure to the meeting
Matters for resolution3 items
Partial Amendment to the Articles of Incorporation
Election of 5 directors (excluding directors who are Audit & Supervisory Committee Members)
Election of 1 director who is an Audit and Supervisory Committee Member
Shareholder Proposal
No
A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.Director nominee
6Nominees
1New
2Outside
| Item | Details |
|---|---|
| Type of shareholders' meeting | Annual, 22nd |
| Date and time | 10:00 a.m., Friday, 26 June 2026 |
| Matters for resolution | Proposal No. 1: Partial Amendment to the Articles of Incorporation, Proposal 2: Election of 5 directors (excluding directors who are Audit & Supervisory Committee Members), Proposal No. 3: Election of 1 director who is an Audit and Supervisory Committee Member |
| Shareholder Proposal | No |
| Director nominee | 6 (including 1 new candidate and 2 outside director candidates) |
Items this document does not state (1)
Percentage voting in favor
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To clarify the two-pronged strategy centered on the cell therapy and equipment and manufacturing sectors, thereby enhancing the company's business expertise and growth potential. In addition, to add business purposes in light of future business expansion.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.